nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—Gadobenate Dimeglumine—ALB—epilepsy syndrome	0.00293	1	CrCbGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC6A8—epilepsy syndrome	0.00285	0.057	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—forebrain—epilepsy syndrome	0.00268	0.154	CbGeAlD
Gadopentetate dimeglumine—PGD—telencephalon—epilepsy syndrome	0.00246	0.141	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—NHLRC1—epilepsy syndrome	0.00218	0.0435	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—EPM2A—epilepsy syndrome	0.00218	0.0435	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—medulla oblongata—epilepsy syndrome	0.00193	0.111	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PFKL—epilepsy syndrome	0.0018	0.0361	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TXNRD1—epilepsy syndrome	0.00178	0.0356	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—midbrain—epilepsy syndrome	0.00177	0.101	CbGeAlD
Gadopentetate dimeglumine—PGD—spinal cord—epilepsy syndrome	0.00172	0.099	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PPP1R3C—epilepsy syndrome	0.00153	0.0307	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—GBE1—epilepsy syndrome	0.00153	0.0307	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—head—epilepsy syndrome	0.00153	0.088	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—ABCC2—epilepsy syndrome	0.0015	0.03	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—nervous system—epilepsy syndrome	0.00145	0.0834	CbGeAlD
Gadopentetate dimeglumine—PGD—central nervous system—epilepsy syndrome	0.0014	0.0803	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC6A1—epilepsy syndrome	0.00139	0.0279	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—cerebellum—epilepsy syndrome	0.00137	0.0785	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—ST3GAL3—epilepsy syndrome	0.00128	0.0255	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC6A4—epilepsy syndrome	0.00111	0.0223	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—brain—epilepsy syndrome	0.00111	0.0637	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC2A1—epilepsy syndrome	0.00101	0.0201	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HBEGF—epilepsy syndrome	0.000947	0.0189	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HMOX1—epilepsy syndrome	0.000829	0.0166	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CA13—epilepsy syndrome	0.000745	0.0149	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PDXK—epilepsy syndrome	0.000674	0.0135	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC2A1—epilepsy syndrome	0.000637	0.0127	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NHLRC1—epilepsy syndrome	0.000617	0.0123	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PNPO—epilepsy syndrome	0.000617	0.0123	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—EPM2A—epilepsy syndrome	0.000617	0.0123	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SV2A—epilepsy syndrome	0.000573	0.0115	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—FAR1—epilepsy syndrome	0.000565	0.0113	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ADK—epilepsy syndrome	0.000565	0.0113	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—L2HGDH—epilepsy syndrome	0.000565	0.0113	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GLUD1—epilepsy syndrome	0.000565	0.0113	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PDXK—epilepsy syndrome	0.000565	0.0113	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CERS1—epilepsy syndrome	0.000565	0.0113	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NHLRC1—epilepsy syndrome	0.000516	0.0103	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—EPM2A—epilepsy syndrome	0.000516	0.0103	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GAMT—epilepsy syndrome	0.000516	0.0103	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PNPO—epilepsy syndrome	0.000516	0.0103	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PFKL—epilepsy syndrome	0.000511	0.0102	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—QDPR—epilepsy syndrome	0.00048	0.0096	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CA4—epilepsy syndrome	0.00048	0.0096	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—STX1B—epilepsy syndrome	0.000467	0.00935	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—COX3—epilepsy syndrome	0.000451	0.00903	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CPSF4—epilepsy syndrome	0.000435	0.00869	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—GBE1—epilepsy syndrome	0.000435	0.00869	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PPP1R3C—epilepsy syndrome	0.000435	0.00869	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CACNA2D2—epilepsy syndrome	0.000428	0.00856	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLCO1A2—epilepsy syndrome	0.000428	0.00856	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PFKL—epilepsy syndrome	0.000428	0.00856	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—KCNB1—epilepsy syndrome	0.000428	0.00856	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC6A8—epilepsy syndrome	0.000428	0.00856	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—UPB1—epilepsy syndrome	0.000391	0.00783	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ATIC—epilepsy syndrome	0.000391	0.00783	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NEU1—epilepsy syndrome	0.000391	0.00783	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HSD17B4—epilepsy syndrome	0.000377	0.00753	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PPP1R3C—epilepsy syndrome	0.000364	0.00728	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GBE1—epilepsy syndrome	0.000364	0.00728	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ST3GAL3—epilepsy syndrome	0.000362	0.00723	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ASAH1—epilepsy syndrome	0.000342	0.00684	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—STXBP1—epilepsy syndrome	0.000333	0.00665	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NT5E—epilepsy syndrome	0.000324	0.00648	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALAD—epilepsy syndrome	0.000324	0.00648	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CACNA1A—epilepsy syndrome	0.000309	0.00619	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALDH7A1—epilepsy syndrome	0.000309	0.00619	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ST3GAL3—epilepsy syndrome	0.000303	0.00605	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ADSL—epilepsy syndrome	0.000297	0.00593	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GLUL—epilepsy syndrome	0.000291	0.00582	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CACNA1D—epilepsy syndrome	0.000286	0.00571	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—TXNRD1—epilepsy syndrome	0.000267	0.00534	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—EIF2AK2—epilepsy syndrome	0.000263	0.00526	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AQP1—epilepsy syndrome	0.000259	0.00518	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PPIA—epilepsy syndrome	0.000244	0.00487	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CHRM3—epilepsy syndrome	0.000234	0.00469	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—KCNJ11—epilepsy syndrome	0.000234	0.00469	CbGpPWpGaD
Gadopentetate dimeglumine—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000221	0.000238	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000221	0.000238	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Clonazepam—epilepsy syndrome	0.000221	0.000238	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Vigabatrin—epilepsy syndrome	0.000221	0.000238	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Valproic Acid—epilepsy syndrome	0.000221	0.000238	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000221	0.000237	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Topiramate—epilepsy syndrome	0.00022	0.000237	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.00022	0.000237	CcSEcCtD
Gadopentetate dimeglumine—Cough—Pregabalin—epilepsy syndrome	0.00022	0.000237	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Phenytoin—epilepsy syndrome	0.00022	0.000236	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000219	0.000236	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Levetiracetam—epilepsy syndrome	0.000219	0.000236	CcSEcCtD
Gadopentetate dimeglumine—Rash—Vigabatrin—epilepsy syndrome	0.000219	0.000236	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Felbamate—epilepsy syndrome	0.000219	0.000236	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Vigabatrin—epilepsy syndrome	0.000219	0.000235	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Topiramate—epilepsy syndrome	0.000219	0.000235	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000218	0.000235	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Pregabalin—epilepsy syndrome	0.000218	0.000235	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000218	0.000235	CcSEcCtD
Gadopentetate dimeglumine—Headache—Vigabatrin—epilepsy syndrome	0.000218	0.000234	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Pregabalin—epilepsy syndrome	0.000218	0.000234	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Diazepam—epilepsy syndrome	0.000218	0.000234	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Valproic Acid—epilepsy syndrome	0.000217	0.000233	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Gabapentin—epilepsy syndrome	0.000216	0.000233	CcSEcCtD
Gadopentetate dimeglumine—Rash—Diazepam—epilepsy syndrome	0.000216	0.000232	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Diazepam—epilepsy syndrome	0.000216	0.000232	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Topiramate—epilepsy syndrome	0.000215	0.000231	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Pregabalin—epilepsy syndrome	0.000215	0.000231	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Pregabalin—epilepsy syndrome	0.000215	0.000231	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Zonisamide—epilepsy syndrome	0.000214	0.000231	CcSEcCtD
Gadopentetate dimeglumine—Headache—Diazepam—epilepsy syndrome	0.000214	0.000231	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Pregabalin—epilepsy syndrome	0.000214	0.00023	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Clonazepam—epilepsy syndrome	0.000214	0.00023	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000213	0.000229	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Valproic Acid—epilepsy syndrome	0.000213	0.000229	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Carbamazepine—epilepsy syndrome	0.000212	0.000229	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Gabapentin—epilepsy syndrome	0.000212	0.000228	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Phenytoin—epilepsy syndrome	0.000212	0.000228	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Fosphenytoin—epilepsy syndrome	0.000212	0.000228	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000211	0.000227	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Topiramate—epilepsy syndrome	0.000211	0.000227	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Gabapentin—epilepsy syndrome	0.000211	0.000227	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000211	0.000227	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Felbamate—epilepsy syndrome	0.000211	0.000226	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Pregabalin—epilepsy syndrome	0.00021	0.000226	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Carbamazepine—epilepsy syndrome	0.00021	0.000225	CcSEcCtD
Gadopentetate dimeglumine—Rash—Felbamate—epilepsy syndrome	0.000209	0.000225	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Topiramate—epilepsy syndrome	0.000209	0.000224	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Felbamate—epilepsy syndrome	0.000209	0.000224	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Gabapentin—epilepsy syndrome	0.000208	0.000224	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Topiramate—epilepsy syndrome	0.000208	0.000224	CcSEcCtD
Gadopentetate dimeglumine—Headache—Felbamate—epilepsy syndrome	0.000207	0.000223	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Pregabalin—epilepsy syndrome	0.000207	0.000223	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000207	0.000223	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Topiramate—epilepsy syndrome	0.000207	0.000223	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Topiramate—epilepsy syndrome	0.000207	0.000223	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Gabapentin—epilepsy syndrome	0.000207	0.000223	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Clonazepam—epilepsy syndrome	0.000207	0.000222	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Vigabatrin—epilepsy syndrome	0.000206	0.000222	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Zonisamide—epilepsy syndrome	0.000206	0.000222	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000206	0.000221	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Lamotrigine—epilepsy syndrome	0.000205	0.000221	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Phenytoin—epilepsy syndrome	0.000205	0.000221	CcSEcCtD
Gadopentetate dimeglumine—Rash—Zonisamide—epilepsy syndrome	0.000204	0.00022	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000204	0.00022	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Zonisamide—epilepsy syndrome	0.000204	0.00022	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000204	0.00022	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Diazepam—epilepsy syndrome	0.000203	0.000219	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000203	0.000218	CcSEcCtD
Gadopentetate dimeglumine—Headache—Zonisamide—epilepsy syndrome	0.000203	0.000218	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000203	0.000218	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000203	0.000218	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Topiramate—epilepsy syndrome	0.000203	0.000218	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Lamotrigine—epilepsy syndrome	0.000203	0.000218	CcSEcCtD
Gadopentetate dimeglumine—Shock—Pregabalin—epilepsy syndrome	0.000202	0.000218	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Valproic Acid—epilepsy syndrome	0.000202	0.000218	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Topiramate—epilepsy syndrome	0.000202	0.000217	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000202	0.000217	CcSEcCtD
Gadopentetate dimeglumine—Cough—Gabapentin—epilepsy syndrome	0.000202	0.000217	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000201	0.000216	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Pregabalin—epilepsy syndrome	0.000201	0.000216	CcSEcCtD
Gadopentetate dimeglumine—Chills—Topiramate—epilepsy syndrome	0.0002	0.000216	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Gabapentin—epilepsy syndrome	0.0002	0.000215	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Pregabalin—epilepsy syndrome	0.0002	0.000215	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Gabapentin—epilepsy syndrome	0.000199	0.000215	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000199	0.000214	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Clonazepam—epilepsy syndrome	0.000199	0.000214	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000198	0.000213	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Phenytoin—epilepsy syndrome	0.000197	0.000212	CcSEcCtD
Gadopentetate dimeglumine—Rash—Clonazepam—epilepsy syndrome	0.000197	0.000212	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Clonazepam—epilepsy syndrome	0.000197	0.000212	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Gabapentin—epilepsy syndrome	0.000197	0.000212	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Gabapentin—epilepsy syndrome	0.000197	0.000212	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Felbamate—epilepsy syndrome	0.000197	0.000212	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000196	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000196	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Valproic Acid—epilepsy syndrome	0.000196	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Gabapentin—epilepsy syndrome	0.000196	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Pregabalin—epilepsy syndrome	0.000196	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Carbamazepine—epilepsy syndrome	0.000196	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000196	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Headache—Clonazepam—epilepsy syndrome	0.000196	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Rash—Phenytoin—epilepsy syndrome	0.000196	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Topiramate—epilepsy syndrome	0.000196	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Phenytoin—epilepsy syndrome	0.000195	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000195	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Rash—Oxcarbazepine—epilepsy syndrome	0.000195	0.000209	CcSEcCtD
Gadopentetate dimeglumine—Pain—Valproic Acid—epilepsy syndrome	0.000195	0.000209	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Valproic Acid—epilepsy syndrome	0.000195	0.000209	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000194	0.000209	CcSEcCtD
Gadopentetate dimeglumine—Headache—Phenytoin—epilepsy syndrome	0.000194	0.000209	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Topiramate—epilepsy syndrome	0.000194	0.000209	CcSEcCtD
Gadopentetate dimeglumine—Headache—Oxcarbazepine—epilepsy syndrome	0.000193	0.000208	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Zonisamide—epilepsy syndrome	0.000193	0.000207	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Gabapentin—epilepsy syndrome	0.000192	0.000207	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Pregabalin—epilepsy syndrome	0.000192	0.000207	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ABCG2—epilepsy syndrome	0.000191	0.00382	CbGpPWpGaD
Gadopentetate dimeglumine—Tension—Topiramate—epilepsy syndrome	0.000191	0.000205	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Topiramate—epilepsy syndrome	0.00019	0.000205	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Gabapentin—epilepsy syndrome	0.00019	0.000205	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Lamotrigine—epilepsy syndrome	0.000189	0.000204	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000189	0.000203	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Carbamazepine—epilepsy syndrome	0.000188	0.000203	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Topiramate—epilepsy syndrome	0.000188	0.000202	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000187	0.000202	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000187	0.000202	CcSEcCtD
Gadopentetate dimeglumine—Rash—Carbamazepine—epilepsy syndrome	0.000187	0.000201	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Carbamazepine—epilepsy syndrome	0.000187	0.000201	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CYP2C19—epilepsy syndrome	0.000186	0.00372	CbGpPWpGaD
Gadopentetate dimeglumine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000186	0.0002	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Clonazepam—epilepsy syndrome	0.000186	0.0002	CcSEcCtD
Gadopentetate dimeglumine—Headache—Carbamazepine—epilepsy syndrome	0.000186	0.0002	CcSEcCtD
Gadopentetate dimeglumine—Shock—Gabapentin—epilepsy syndrome	0.000186	0.0002	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CYP11A1—epilepsy syndrome	0.000185	0.0037	CbGpPWpGaD
Gadopentetate dimeglumine—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000185	0.000199	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Pregabalin—epilepsy syndrome	0.000185	0.000199	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Phenytoin—epilepsy syndrome	0.000184	0.000198	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Gabapentin—epilepsy syndrome	0.000184	0.000198	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Pregabalin—epilepsy syndrome	0.000183	0.000197	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Oxcarbazepine—epilepsy syndrome	0.000183	0.000197	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Gabapentin—epilepsy syndrome	0.000183	0.000197	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Pregabalin—epilepsy syndrome	0.000183	0.000197	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000182	0.000196	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Topiramate—epilepsy syndrome	0.000182	0.000196	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Lamotrigine—epilepsy syndrome	0.000182	0.000196	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Valproic Acid—epilepsy syndrome	0.000181	0.000194	CcSEcCtD
Gadopentetate dimeglumine—Rash—Lamotrigine—epilepsy syndrome	0.00018	0.000194	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SLC2A1—epilepsy syndrome	0.00018	0.00361	CbGpPWpGaD
Gadopentetate dimeglumine—Dermatitis—Lamotrigine—epilepsy syndrome	0.00018	0.000194	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Valproic Acid—epilepsy syndrome	0.00018	0.000193	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Valproic Acid—epilepsy syndrome	0.00018	0.000193	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Gabapentin—epilepsy syndrome	0.00018	0.000193	CcSEcCtD
Gadopentetate dimeglumine—Headache—Lamotrigine—epilepsy syndrome	0.000179	0.000193	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—JUNB—epilepsy syndrome	0.000179	0.00358	CbGpPWpGaD
Gadopentetate dimeglumine—Decreased appetite—Pregabalin—epilepsy syndrome	0.000179	0.000192	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Topiramate—epilepsy syndrome	0.000179	0.000192	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—NOS1—epilepsy syndrome	0.000178	0.00356	CbGpPWpGaD
Gadopentetate dimeglumine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000178	0.000191	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Pregabalin—epilepsy syndrome	0.000177	0.000191	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Gabapentin—epilepsy syndrome	0.000176	0.00019	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Carbamazepine—epilepsy syndrome	0.000176	0.000189	CcSEcCtD
Gadopentetate dimeglumine—Pain—Pregabalin—epilepsy syndrome	0.000176	0.000189	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Pregabalin—epilepsy syndrome	0.000176	0.000189	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Topiramate—epilepsy syndrome	0.000175	0.000189	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Topiramate—epilepsy syndrome	0.000174	0.000188	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000172	0.000185	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Topiramate—epilepsy syndrome	0.000171	0.000184	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Lamotrigine—epilepsy syndrome	0.00017	0.000183	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—HBEGF—epilepsy syndrome	0.00017	0.00339	CbGpPWpGaD
Gadopentetate dimeglumine—Cough—Topiramate—epilepsy syndrome	0.00017	0.000182	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000169	0.000182	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Gabapentin—epilepsy syndrome	0.000169	0.000182	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Topiramate—epilepsy syndrome	0.000168	0.000181	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000168	0.000181	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Gabapentin—epilepsy syndrome	0.000168	0.000181	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Topiramate—epilepsy syndrome	0.000168	0.000181	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Gabapentin—epilepsy syndrome	0.000168	0.00018	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000168	0.00018	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CYP2D6—epilepsy syndrome	0.000167	0.00334	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AKT3—epilepsy syndrome	0.000167	0.00333	CbGpPWpGaD
Gadopentetate dimeglumine—Chest pain—Topiramate—epilepsy syndrome	0.000165	0.000178	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Topiramate—epilepsy syndrome	0.000165	0.000178	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Topiramate—epilepsy syndrome	0.000165	0.000177	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000164	0.000177	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Gabapentin—epilepsy syndrome	0.000164	0.000176	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Pregabalin—epilepsy syndrome	0.000163	0.000176	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Valproic Acid—epilepsy syndrome	0.000163	0.000176	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000163	0.000175	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—ADAM10—epilepsy syndrome	0.000163	0.00325	CbGpPWpGaD
Gadopentetate dimeglumine—Fatigue—Gabapentin—epilepsy syndrome	0.000163	0.000175	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Pregabalin—epilepsy syndrome	0.000163	0.000175	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Pregabalin—epilepsy syndrome	0.000163	0.000175	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Topiramate—epilepsy syndrome	0.000162	0.000174	CcSEcCtD
Gadopentetate dimeglumine—Pain—Gabapentin—epilepsy syndrome	0.000161	0.000173	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Gabapentin—epilepsy syndrome	0.000161	0.000173	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Valproic Acid—epilepsy syndrome	0.000161	0.000173	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Topiramate—epilepsy syndrome	0.00016	0.000172	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ADRA2A—epilepsy syndrome	0.000159	0.00318	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—BCHE—epilepsy syndrome	0.000158	0.00317	CbGpPWpGaD
Gadopentetate dimeglumine—Shock—Topiramate—epilepsy syndrome	0.000156	0.000168	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000156	0.000167	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Topiramate—epilepsy syndrome	0.000156	0.000167	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000155	0.000167	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Topiramate—epilepsy syndrome	0.000155	0.000167	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000154	0.000166	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Topiramate—epilepsy syndrome	0.000154	0.000166	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000153	0.000165	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CDC42—epilepsy syndrome	0.000152	0.00304	CbGpPWpGaD
Gadopentetate dimeglumine—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000151	0.000163	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Topiramate—epilepsy syndrome	0.000151	0.000163	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—SLC2A1—epilepsy syndrome	0.000151	0.00302	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Valproic Acid—epilepsy syndrome	0.00015	0.000162	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Gabapentin—epilepsy syndrome	0.00015	0.000161	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PLCB1—epilepsy syndrome	0.000149	0.00299	CbGpPWpGaD
Gadopentetate dimeglumine—Abdominal pain—Gabapentin—epilepsy syndrome	0.000149	0.00016	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Gabapentin—epilepsy syndrome	0.000149	0.00016	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—TH—epilepsy syndrome	0.000149	0.00298	CbGpPWpGaD
Gadopentetate dimeglumine—Hypotension—Topiramate—epilepsy syndrome	0.000148	0.000159	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Pregabalin—epilepsy syndrome	0.000148	0.000159	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Pregabalin—epilepsy syndrome	0.000145	0.000156	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Valproic Acid—epilepsy syndrome	0.000145	0.000156	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000145	0.000155	CcSEcCtD
Gadopentetate dimeglumine—Rash—Valproic Acid—epilepsy syndrome	0.000143	0.000154	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Valproic Acid—epilepsy syndrome	0.000143	0.000154	CcSEcCtD
Gadopentetate dimeglumine—Headache—Valproic Acid—epilepsy syndrome	0.000142	0.000153	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Topiramate—epilepsy syndrome	0.000142	0.000153	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Topiramate—epilepsy syndrome	0.000141	0.000152	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Topiramate—epilepsy syndrome	0.000141	0.000152	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Pregabalin—epilepsy syndrome	0.000141	0.000151	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—HES1—epilepsy syndrome	0.000139	0.00278	CbGpPWpGaD
Gadopentetate dimeglumine—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000139	0.000149	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Topiramate—epilepsy syndrome	0.000138	0.000148	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000137	0.000147	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Topiramate—epilepsy syndrome	0.000137	0.000147	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Pregabalin—epilepsy syndrome	0.000136	0.000146	CcSEcCtD
Gadopentetate dimeglumine—Pain—Topiramate—epilepsy syndrome	0.000136	0.000146	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Topiramate—epilepsy syndrome	0.000136	0.000146	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Gabapentin—epilepsy syndrome	0.000135	0.000146	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—FYN—epilepsy syndrome	0.000135	0.0027	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Valproic Acid—epilepsy syndrome	0.000135	0.000145	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—H2AFX—epilepsy syndrome	0.000135	0.00269	CbGpPWpGaD
Gadopentetate dimeglumine—Pruritus—Gabapentin—epilepsy syndrome	0.000133	0.000143	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Pregabalin—epilepsy syndrome	0.000131	0.000141	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Topiramate—epilepsy syndrome	0.000131	0.000141	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—YWHAZ—epilepsy syndrome	0.00013	0.0026	CbGpPWpGaD
Gadopentetate dimeglumine—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.00013	0.00014	CcSEcCtD
Gadopentetate dimeglumine—Rash—Pregabalin—epilepsy syndrome	0.00013	0.000139	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Pregabalin—epilepsy syndrome	0.00013	0.000139	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Gabapentin—epilepsy syndrome	0.000129	0.000139	CcSEcCtD
Gadopentetate dimeglumine—Headache—Pregabalin—epilepsy syndrome	0.000129	0.000139	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Topiramate—epilepsy syndrome	0.000126	0.000136	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Topiramate—epilepsy syndrome	0.000125	0.000135	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Topiramate—epilepsy syndrome	0.000125	0.000135	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CCR5—epilepsy syndrome	0.000125	0.0025	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Gabapentin—epilepsy syndrome	0.000125	0.000134	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—HMOX1—epilepsy syndrome	0.000124	0.00249	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CAT—epilepsy syndrome	0.000123	0.00245	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Pregabalin—epilepsy syndrome	0.000122	0.000131	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Gabapentin—epilepsy syndrome	0.00012	0.000129	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ABCB1—epilepsy syndrome	0.000119	0.00239	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Gabapentin—epilepsy syndrome	0.000119	0.000128	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Gabapentin—epilepsy syndrome	0.000119	0.000128	CcSEcCtD
Gadopentetate dimeglumine—Headache—Gabapentin—epilepsy syndrome	0.000118	0.000127	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Topiramate—epilepsy syndrome	0.000117	0.000126	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—TSC2—epilepsy syndrome	0.000116	0.00232	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Topiramate—epilepsy syndrome	0.000114	0.000122	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—APOE—epilepsy syndrome	0.000114	0.00227	CbGpPWpGaD
Gadopentetate dimeglumine—Pruritus—Topiramate—epilepsy syndrome	0.000112	0.000121	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Gabapentin—epilepsy syndrome	0.000112	0.00012	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—GPX1—epilepsy syndrome	0.000111	0.00222	CbGpPWpGaD
Gadopentetate dimeglumine—Diarrhoea—Topiramate—epilepsy syndrome	0.000109	0.000117	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—IL6ST—epilepsy syndrome	0.000107	0.00214	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NOS2—epilepsy syndrome	0.000106	0.00212	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Topiramate—epilepsy syndrome	0.000105	0.000113	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Topiramate—epilepsy syndrome	0.000101	0.000108	CcSEcCtD
Gadopentetate dimeglumine—Rash—Topiramate—epilepsy syndrome	0.0001	0.000108	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Topiramate—epilepsy syndrome	9.99e-05	0.000107	CcSEcCtD
Gadopentetate dimeglumine—Headache—Topiramate—epilepsy syndrome	9.94e-05	0.000107	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—AGT—epilepsy syndrome	9.73e-05	0.00194	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—APOE—epilepsy syndrome	9.53e-05	0.00191	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Topiramate—epilepsy syndrome	9.42e-05	0.000101	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—FGF2—epilepsy syndrome	8.64e-05	0.00173	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—POMC—epilepsy syndrome	8.19e-05	0.00164	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MTOR—epilepsy syndrome	7.87e-05	0.00157	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PTGS2—epilepsy syndrome	7.8e-05	0.00156	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALB—epilepsy syndrome	7.46e-05	0.00149	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PTGS2—epilepsy syndrome	6.53e-05	0.00131	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SRC—epilepsy syndrome	6.31e-05	0.00126	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AKT1—epilepsy syndrome	3.92e-05	0.000783	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AKT1—epilepsy syndrome	3.28e-05	0.000656	CbGpPWpGaD
